Moreover, after binding CTCs, platelets secrete TGF-β and platelet-derived growth factor (PDGF), which maintains the EMT state of tumor cells and contributes to immunosuppression of circulating NK cells [47, 83–85]. Here, TGFB1 is linked to neoplasm.